clear cell renal cell carcinoma
Survival Benefit Seen With Adjuvant Therapy in Patients With ccRCC
Adjuvant pembrolizumab (Keytruda, Merck) significantly improved overall survival in patients with clear cell renal ...
FEBRUARY 14, 2024
Sorafenib and Sunitinib Similar to Placebo in High-Risk RCC Patients
Neither sorafenib nor sunitinib appeared to be more effective than placebo at improving disease-free survival in ...
APRIL 13, 2017
Biomarker Score Helps Predict Recurrence in Clear Cell RCC
A new biomarker-based scoring system can help identify patients with clear cell renal cell carcinoma.
FEBRUARY 8, 2017
Load more